Carter Bankshares’ Q1 2026: One-Time Loan Sale Lifts EPS, Shrinks NPLs, and Signals a Sector Rebalancing
Ticker: CARE • EPS reported: $3.88 diluted in Q1 2026 • EPS consensus not published in the filing • revenue forecast not provided; investors will watch for ongoing earnings trajectory beyond the one-time effects.
In the first quarter of 2026, Carter Bankshares, Inc. (NASDAQ: CARE) posted a quarterly net income of $85.8 million, equating to $3.88 per share on a diluted basis, up from $9.0 million and $0.39 EPS in Q1 2025. The numbers reflect the headline earnings that come with a material asset disposition rather than a pure operating run-rate improvement.
Transaction that Overshadowed the Quarter
The Company completed the sale of all loans—later reduced to judgments tied to entities with ties to James C. Justice, II—in a transaction described as an absolute, “as-is, where-is” sale to an unaffiliated third party. The consideration: $289.5 million in cash. Immediately prior to the sale, the loan portfolio carried an outstanding principal of $209.5 million, all nonperforming and on nonaccrual, with a specific reserve of $18.0 million booked as of December 31, 2025.
The sale produced a net gain of $80.0 million for the quarter and increased cash by the $289.5 million consideration. The Company also released $18.0 million of specific reserves related to the Loans and, importantly, the transaction was accretive to diluted EPS by $3.50 for the quarter.
Impact on Earnings, Capital, and Book Value
The highlights for the quarter include:
- Net interest income of $35.9 million for Q1 2026, up from $34.6 million in Q4 2025 and $30.1 million in Q1 2025.
- Transaction-related earnings: $80.0 million net gain, with the remaining around-the-margin effects from the sale.
- Book value per share and tangible book value per share each rose by $3.49 due to the Transaction.
- The Transaction was accretive to diluted EPS by $3.50 for the quarter.
From a capital-angle lens, the sale clearly changed the balance sheet and the earnings profile in the quarter. It reduces the loan book and nonperforming risk, while boosting near-term per-share metrics. Analysts will need to distinguish this one-time uplift from ongoing profitability as they model future periods.
Asset Quality: NPLs and the New Normal
Nonperforming loans (NPLs) decreased materially, to $24.0 million as of March 31, 2026, from $244.0 million at December 31, 2025, reflecting the Transaction’s impact. The NPL ratio fell to 0.64% of gross loans at March 31, 2026, compared with 6.29% at December 31, 2025 and 7.09% at March 31, 2025.
Even with a smaller, tidier loan book, the bank reported a net loan decrease of $151.1 million at March 31, 2026 from December 31, 2025 due to the Transaction. Net loan growth during the quarter was $58.4 million, or 6.1% on an annualized basis, partially offset by the sale. In short: the asset-quality move is dramatic, and the credit-cost story is tempered by a one-off exit from a weak portfolio.
Operational Rhythm and Interest Earnings
Net interest income rose quarter over quarter, totaling $35.9 million in Q1 2026—the quarter’s backdrop features more conservative credit exposure after the loan sale and a still-healthy interest-income engine. The report notes a 15-basis-point uplift in net interest margin to 3.07% for Q1 2026, with a 39-basis-point improvement versus the prior-year quarter.
While the headline numbers look favorable, the underlying message is a blend of one-off gain and a tighter balance sheet. The narrative for the coming quarters will hinge on how much recurring earnings can be supported by core lending and deposit activity once the Transaction effects normalize.
What It Could Portend for Carter Bankshares and Peers
The Q1 2026 results illustrate a privilégié approach to de-risking: use a selective sale to remove underperforming assets, lift per-share metrics, and free up capital. For CARE, the immediate effect is a higher EPS for the quarter, a higher BVPS, and a leaner loan book. The risk is reliance on a one-time event to drive earnings visibility, which makes the sustainability of the earnings story less clear beyond the current period.
For sector peers, the move hints at a trend toward credit-quality optimization via asset dispositions. If more banks pursue similar de-risking, we could see a broader relief in NPL ratios across the sector and a re-rating of banks with high nonperforming exposure. Yet investors should beware that this is not a universal switch to higher-lending profitability; it is, in large part, a repositioning tied to the specific loan portfolio and its sale terms. In other words, don’t mistake a one-off transaction for a new business model.
Analyst Framing: EPS, Revenue Preview, and the Road Ahead
Without a published EPS consensus or a formal revenue forecast in the filing, the quarter’s reported EPS of $3.88 and the $3.50 per-share impact from the Transaction will be weighed against ongoing operating performance and debt-management strategy. The absence of a stated revenue forecast means the market will default to a watching brief on how loan originations and net interest income evolve in the next few quarters.
Matt Levine might put it this way: the math checks out for the quarter, but the story’s main plot twist is whether the bank can repeat a portion of this EPS uplift through ordinary-course operations, not just a windfall from asset disposals. If peers see similar precautionary asset sales, lenders may begin to trade higher on de-risking narratives—but the longer-term multiple remains tethered to loan growth, net interest income stability, and reserve adequacy.
Bottom Line
The Q1 2026 print for Carter Bankshares is a textbook case of a strategic one-off: a sizable cash sale of underperforming assets creates immediate EPS lift, reduces credit risk, and reshapes the balance sheet in a way that should help capital and TBV over the near term. The challenge for CARE and its peers is translating this repositioning into sustainable earnings power that endures beyond the quarter and into a more predictable revenue trajectory.